CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
CVX distributes $6 billion to its shareholders, including $2.5 billion in buybacks and $3.5 billion in dividends during the first quarter
NOV Q1 earnings miss estimates as Middle East disruptions hit operations, while revenues edge past expectations despite a year-over-year decline.
Core Laboratories (NYSE:CLB) executives said first-quarter 2026 results were significantly affected by geopolitical and weather-related disruptions, with the escalation of military conflict in the Middle East creating meaningful project delays, halting some hydrocarbon production, and disrupting mar